Tango Therapeutics has announced several leadership changes, appointing Matthew Gall as Chief Financial Officer, Yen-Ching Chua as Chief Development Operations Officer effective June 1, 2026, and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results